The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Switching patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP) with residual disease on long-term imatinib (IM) to nilotinib (NIL): ENESTcmr 24-mo follow-up.
Nelson Spector
Research Funding - Novartis
Brian Leber
Consultant or Advisory Role - Novartis
Honoraria - Novartis
Research Funding - Novartis
Jeffrey Howard Lipton
Consultant or Advisory Role - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer; Teva
Stock Ownership - ARIAD
Honoraria - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer; Teva
Research Funding - Bristol-Myers Squibb; Novartis
Carmino De Souza
Research Funding - Novartis
Beatriz Moiraghi
Consultant or Advisory Role - Bristol-Myers Squibb
Juan Luis Steegmann
Consultant or Advisory Role - Bristol-Myers Squibb; Novartis; Pfizer
Honoraria - Bristol-Myers Squibb; Novartis; Pfizer
Anthony P. Schwarer
Consultant or Advisory Role - ARIAD; Bristol-Myers Squibb; Novartis
Honoraria - ARIAD; Bristol-Myers Squibb; Novartis
Francisco Cervantes
Consultant or Advisory Role - Novartis; Pfizer; Sanofi
Honoraria - Bristol-Myers Squibb; Novartis
Timothy P. Hughes
Consultant or Advisory Role - ARIAD; Bristol-Myers Squibb; Novartis
Honoraria - ARIAD; Bristol-Myers Squibb; Novartis
Research Funding - ARIAD; Bristol-Myers Squibb; Novartis
Das Purkayastha
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
LaTonya R Collins
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Tomasz K. Szczudlo
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Delphine Rea
Honoraria - Novartis